Implications for Patients and Providers The rise in reported deaths underscores the need for: Informed consent : Patients must be fully briefed on potential risks and benefits before starting GLP-1RA therapy Routine monitoring : Regular follow-up appointments and lab tests are essential to detect early signs of adverse reactions Avoidance of unregulated sources : Patients should never purchase GLP-1RA drugs from unofficial vendors or social media platforms Legal recourse : Individuals harmed by GLP-1RA drugs may be eligible to pursue legal claims, especially in cases involving off-label promotion, defective products, or lack of warning
We rated the certainty for each comparison and outcome as high, moderate, low, or very low, taking into consideration the risk of bias [26], inconsistency [27], imprecision [28, 29], indirectness [30], and publication bias [31]
Portuguese Pediatr
SGLT-2 inhibitors are superior to GLP-1 receptor agonists in improving cardiovascular and renal outcomes, except for nonfatal stroke
If you are being treated for an illness, are pregnant or breastfeeding, consult your doctor before using dietary supplements
Add fresh lemon, mint, or berries for variety without sugar